BridgeMD
New treatment option for Stroke, Acute
Official title Exploring Motor Learning in Acute Stroke Through Robotics
ClinicalTrials.gov ID: NCT04171856
What this study is testing
- What it's testing
- The acute phase of stroke is characterized by an enhancement of neural plasticity which supports rapid motor recovery. It is unclear whether acute stroke patients can acquire new motor skills with their affected upper limb.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90. Healthy volunteers may be eligible.
You may be able to join if
- ACUTE STROKE PATIENTS:
- acute stroke (\> 21 days)
- aged 18-90 years
- with a stroke lesion on brain imaging
You likely can't join if
- " classical " contre-indication to MRI (non-MR-compatible pacemaker, pregnancy, non-MR-compatible implanted devices, claustrophoby, etc ...)
- difficulty in understanding or executing commands
- drug/alcohol abuse
- severe aphasia / cognitive deficits interfering with study
- inability to voluntarily move the affected arm (i.e. complete paralysis of the arm)
- multiple strokes / dementia / psychiatric condition PATIENTS WITH TRANSIENT GLOBAL AMNESIA: Clinical diagnosis, criteria of Hodge \& Warlow (1990):
See the full eligibility criteria
- ACUTE STROKE PATIENTS:
- acute stroke (\> 21 days)
- aged 18-90 years
- with a stroke lesion on brain imaging
- " classical " contre-indication to MRI (non-MR-compatible pacemaker, pregnancy, non-MR-compatible implanted devices, claustrophoby, etc ...)
- difficulty in understanding or executing commands
- drug/alcohol abuse
- severe aphasia / cognitive deficits interfering with study
- inability to voluntarily move the affected arm (i.e. complete paralysis of the arm)
- multiple strokes / dementia / psychiatric condition PATIENTS WITH TRANSIENT GLOBAL AMNESIA: Clinical diagnosis, criteria of Hodge \& Warlow (1990):
- Anterograde amnesia observed by a witness
- No alteration of consciousness or loss of identity
- Cognitive dysfunction limited to amnesia
- Lack of focused neurological deficit or argument for a comitiality
- Absence of head trauma
- Symptom resolution within 24 hours
- Possible existence of vegetative symptoms Inclusion criteria:
- Transient global amnesia
- 8-90 years old
- Be able to perform 3 consecutive sessions on a rehabilitation robot Exclusion criteria:
- Severe aphasia / cognitive deficits interfering with study
- Psychiatric disorders
- Alcohol / drug addiction
- Exclusion criteria related to MRI HEALTHY INDIVIDUALS: Inclusion Criteria:
- 18-90 years Exclusion Criteria:
- medical history with a previous stroke/neurological deficit
- drug/alcohol abuse
- psychiatric condition/ dementia CHRONIC STROKE PATIENTS: Inclusion Criteria:
- chronic stroke (\>6 months)
- aged 18-90 years
- with a stroke lesion on brain imaging Exclusion Criteria:
- difficulty in understanding or executing commands
- drug/alcohol abuse
- severe aphasia / cognitive deficits interfering with study
- inability to voluntarily move the affected arm (i.e. complete paralysis of the arm)
- multiple strokes / dementia / psychiatric condition
The study team makes the final eligibility decision.
Where it's taking place
- Yvoir, Namur, Belgium
- Yvoir, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Yvoir, Namur, Belgium; Yvoir, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.